Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B2 | P19099 | 6/20 | 0.39 |
| ▸ | CYP11B1 | P15538 | 3/20 | 0.39 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.39 |
| ▸ | PARP11 | Q9NR21 | 1/20 | 0.39 |
| ▸ | CHRNA7 | P36544 | 3/20 | 0.38 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.38 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.38 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.38 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.38 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.35 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.35 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.35 |
| ▸ | IDH1 | O75874 | 1/20 | 0.35 |
| ▸ | TRPV3 | Q8NET8 | 1/20 | 0.34 |
| ▸ | TNF | P01375 | 1/20 | 0.34 |
| ▸ | PIM1 | P11309 | 1/20 | 0.34 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30641499 | 1.00 | CYP11B2 (0.39) | CYP11B2CYP11B1PARP10PARP11CHRNA7 | |
| Hydrochloric Acid SCHEMBL26638291 | 0.98 | CYP11B2 (0.38) | CYP11B2CYP11B1PARP10PARP11CHRNA7 | |
| Hydrochloric Acid SCHEMBL30587451 | 0.98 | CYP11B2 (0.38) | CYP11B2CYP11B1PARP10PARP11CHRNA7 | |
| Hydrochloric Acid SCHEMBL30698324 | 0.98 | CYP11B2 (0.38) | CYP11B2CYP11B1PARP10PARP11CHRNA7 | |
| Hydrochloric Acid SCHEMBL29147846 | 0.98 | CYP11B2 (0.38) | CYP11B2CYP11B1PARP10PARP11CHRNA7 | |
| SCHEMBL6407483 | 0.82 | KDM1A (0.39) | — | |
| SCHEMBL311778 | 0.77 | IDO1 (0.54) | — | |
| SCHEMBL18051397 | 0.75 | NOTUM (0.44) | — | |
| SCHEMBL21744244 | 0.75 | CYP11B2 (0.56) | CYP11B2CYP11B1PARP10PARP11CHRNA7 | |
| SCHEMBL785845 | 0.75 | KIF11 (0.45) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230365621-A1 | ANALOGS OF CDDO-2P-IM AND CDDO-3P-IM | TRITERPENOID THERAPEUTICS INC (US) | 2023-11-16 | — | — | US | disclosed |
| US-20230365621-A1 | ANALOGS OF CDDO-2P-IM AND CDDO-3P-IM | TRITERPENOID THERAPEUTICS INC (US) | 2023-11-16 | — | — | US | disclosed |
| WO-2022056439-A1 | ANALOGS OF CDDO-2P-IM AND CDDO-3P-IM | TRITERPENOID THERAPEUTICS, INC. (US) | 2022-03-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230365621-A1 | ANALOGS OF CDDO-2P-IM AND CDDO-3P-IM | CDYL2, CYP11B2, HSD17B13 | CYP11B2 2/4885CYP11B1 6/4885PARP10 1319/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.